Li, Josephine H.
Florez, Jose C.
Funding for this research was provided by:
Massachusetts General Hospital (ECOR Fund for Medical Discovery Clinical Research Fellowship Award)
National Institute of General Medical Sciences (R01 GM117163)
National Institute of Diabetes and Digestive and Kidney Diseases (UM1 DK126185, R01 DK123019, U54 DK118612)
National Heart, Lung, and Blood Institute (K24 HL157960)
Article History
Accepted: 29 August 2022
First Online: 19 September 2022
Declarations
:
: JHL is partially supported by an MGH ECOR Fund for Medical Discovery Clinical Research Fellowship Award. JCF is the recipient of NIH Grants R01 GM117163, UM1 DK126185, R01 DK123019, U54 DK118612, and K24 HL157960 relevant to this work.
: Josephine H. Li has no competing interests to declare that are relevant to the content of this article. Jose C. Florez has received speaking honoraria from Novo Nordisk, AstraZeneca, and Merck for research lectures over which he had full control of the content, and has also received consulting honoraria from AstraZeneca and Novo Nordisk.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: Both authors wrote and edited this manuscript, and read and approved the final version.